Lewis R. Vidler

924 total citations
16 papers, 652 citations indexed

About

Lewis R. Vidler is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Lewis R. Vidler has authored 16 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Computational Theory and Mathematics and 3 papers in Organic Chemistry. Recurrent topics in Lewis R. Vidler's work include Computational Drug Discovery Methods (5 papers), Chemical Synthesis and Analysis (4 papers) and Protein Degradation and Inhibitors (4 papers). Lewis R. Vidler is often cited by papers focused on Computational Drug Discovery Methods (5 papers), Chemical Synthesis and Analysis (4 papers) and Protein Degradation and Inhibitors (4 papers). Lewis R. Vidler collaborates with scholars based in United Kingdom, United States and Japan. Lewis R. Vidler's co-authors include Swen Hoelder, Stefan Knapp, Nathan Brown, David Collier, O. Fedorov, Daniel Ursu, Deb K. Pal, Laura Addis, Hannah L. Woodward and P. Filippakopoulos and has published in prestigious journals such as Bioinformatics, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Lewis R. Vidler

16 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lewis R. Vidler United Kingdom 10 480 171 109 91 81 16 652
Justin M. Di Trani Canada 12 353 0.7× 78 0.5× 38 0.3× 46 0.5× 44 0.5× 20 519
Vladimiras Oleinikovas United Kingdom 6 375 0.8× 19 0.1× 86 0.8× 29 0.3× 118 1.5× 7 430
Daniel Riester Germany 17 861 1.8× 15 0.1× 41 0.4× 169 1.9× 43 0.5× 25 1.1k
Pierrick Craveur France 14 413 0.9× 13 0.1× 29 0.3× 34 0.4× 102 1.3× 17 503
Simon Mitternacht Sweden 13 534 1.1× 11 0.1× 160 1.5× 28 0.3× 139 1.7× 17 627
Martin Klumpp Switzerland 15 581 1.2× 14 0.1× 58 0.5× 25 0.3× 255 3.1× 19 670
Gilles Tiraboschi France 10 253 0.5× 9 0.1× 45 0.4× 56 0.6× 57 0.7× 14 403
Ana I. Azuaga Spain 15 489 1.0× 18 0.1× 21 0.2× 13 0.1× 174 2.1× 25 622
Martin Kulke Germany 10 211 0.4× 13 0.1× 46 0.4× 22 0.2× 42 0.5× 25 358
Ilona Christy Unarta Hong Kong 13 367 0.8× 11 0.1× 26 0.2× 17 0.2× 67 0.8× 28 470

Countries citing papers authored by Lewis R. Vidler

Since Specialization
Citations

This map shows the geographic impact of Lewis R. Vidler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis R. Vidler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis R. Vidler more than expected).

Fields of papers citing papers by Lewis R. Vidler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis R. Vidler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis R. Vidler. The network helps show where Lewis R. Vidler may publish in the future.

Co-authorship network of co-authors of Lewis R. Vidler

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis R. Vidler. A scholar is included among the top collaborators of Lewis R. Vidler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis R. Vidler. Lewis R. Vidler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bruffaerts, Jeffrey, Luigi Stasi, Bénédicte Lallemand, et al.. (2023). Design of Novel Series of Antimalarial PMX Inhibitors with Increased Half-Life via Molecular Property Optimization. ACS Medicinal Chemistry Letters. 14(11). 1582–1588. 5 indexed citations
2.
Foster, Holly, Clare Wilson, Julia S. Gauer, et al.. (2022). A Comparative Assessment Study of Known Small-molecule GPVI Modulators. ACS Medicinal Chemistry Letters. 13(2). 171–181. 6 indexed citations
3.
Jones, Simon, James D. Firth, Masakazu Atobe, et al.. (2022). Exploration of piperidine 3D fragment chemical space: synthesis and 3D shape analysis of fragments derived from 20 regio- and diastereoisomers of methyl substituted pipecolinates. RSC Medicinal Chemistry. 13(12). 1614–1620. 4 indexed citations
4.
Downes, Thomas D., Simon Jones, Hanna F. Klein, et al.. (2020). Design and Synthesis of 56 Shape‐Diverse 3D Fragments. Chemistry - A European Journal. 26(41). 8969–8975. 39 indexed citations
5.
Vidler, Lewis R., P. J. Simpson, Bissan Al‐Lazikani, et al.. (2020). Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches. Scientific Reports. 10(1). 16000–16000. 11 indexed citations
6.
Vidler, Lewis R. & Matthew P. Baumgartner. (2019). Creating a Virtual Assistant for Medicinal Chemistry. ACS Medicinal Chemistry Letters. 10(7). 1051–1055. 9 indexed citations
7.
Pearson, Neil D., Karim Malki, David A. Evans, et al.. (2019). TractaViewer: a genome-wide tool for preliminary assessment of therapeutic target druggability. Bioinformatics. 35(21). 4509–4510. 5 indexed citations
8.
Vidler, Lewis R., et al.. (2018). Investigating the Behavior of Published PAINS Alerts Using a Pharmaceutical Company Data Set. ACS Medicinal Chemistry Letters. 9(8). 792–796. 24 indexed citations
9.
10.
Tortorici, Marcello, et al.. (2017). Structure‐Enabled Discovery of a Stapled Peptide Inhibitor to Target the Oncogenic Transcriptional Repressor TLE1. Chemistry - A European Journal. 23(40). 9577–9584. 11 indexed citations
11.
Jong, Simone de, Lewis R. Vidler, Younes Mokrab, David Collier, & Gerome Breen. (2016). Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia. Journal of Psychopharmacology. 30(8). 826–830. 18 indexed citations
12.
Vidler, Lewis R., A. Chaikuad, Octovia Monteiro, et al.. (2015). Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B. Journal of Medicinal Chemistry. 58(5). 2553–2559. 71 indexed citations
13.
Gao, Cen, et al.. (2015). Beyond PAINs: Chemotype Sensitivity of Protein Methyltransferases in Screens. ACS Medicinal Chemistry Letters. 7(2). 156–161. 4 indexed citations
14.
Vidler, Lewis R., P. Filippakopoulos, O. Fedorov, et al.. (2013). Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening. Journal of Medicinal Chemistry. 56(20). 8073–8088. 101 indexed citations
15.
Vidler, Lewis R., Nathan Brown, Stefan Knapp, & Swen Hoelder. (2012). Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites. Journal of Medicinal Chemistry. 55(17). 7346–7359. 203 indexed citations
16.
Allain, Clémence, Lewis R. Vidler, Michael C. Willis, et al.. (2009). Changing the local coordination environment in mono- and bi- nuclear lanthanide complexes through “click” chemistry. Dalton Transactions. 6283–6283. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justin M. Di Trani Breakdown of academic impact, for papers by Vladimiras Oleinikovas Breakdown of academic impact, for papers by Daniel Riester Breakdown of academic impact, for papers by Pierrick Craveur Breakdown of academic impact, for papers by Simon Mitternacht Breakdown of academic impact, for papers by Martin Klumpp Breakdown of academic impact, for papers by Gilles Tiraboschi Breakdown of academic impact, for papers by Ana I. Azuaga Breakdown of academic impact, for papers by Martin Kulke Breakdown of academic impact, for papers by Ilona Christy Unarta
Rankless by CCL
2026